189 related articles for article (PubMed ID: 35464749)
21. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
22. The 2020 Pandemic: Current SARS-CoV-2 Vaccine Development.
Alturki SO; Alturki SO; Connors J; Cusimano G; Kutzler MA; Izmirly AM; Haddad EK
Front Immunol; 2020; 11():1880. PubMed ID: 32973779
[TBL] [Abstract][Full Text] [Related]
23. Severe acute respiratory syndrome coronavirus 2(SARS-CoV-2) infection during late pregnancy: a report of 18 patients from Wuhan, China.
Zhang L; Dong L; Ming L; Wei M; Li J; Hu R; Yang J
BMC Pregnancy Childbirth; 2020 Jul; 20(1):394. PubMed ID: 32641013
[TBL] [Abstract][Full Text] [Related]
24. Long COVID.
Guziejko K; Tałałaj J; Czupryna P; Moniuszko-Malinowska A
Przegl Epidemiol; 2022; 76(3):287-295. PubMed ID: 36520039
[TBL] [Abstract][Full Text] [Related]
25. Early prediction of level-of-care requirements in patients with COVID-19.
Hao B; Sotudian S; Wang T; Xu T; Hu Y; Gaitanidis A; Breen K; Velmahos GC; Paschalidis IC
Elife; 2020 Oct; 9():. PubMed ID: 33044170
[TBL] [Abstract][Full Text] [Related]
26. Novel coronavirus disease 2019 (COVID-19) and neurodegenerative disorders.
Singh AK; Bhushan B; Maurya A; Mishra G; Singh SK; Awasthi R
Dermatol Ther; 2020 Jul; 33(4):e13591. PubMed ID: 32412679
[TBL] [Abstract][Full Text] [Related]
27. Comparison of Four Molecular
Zhen W; Manji R; Smith E; Berry GJ
J Clin Microbiol; 2020 Jul; 58(8):. PubMed ID: 32341143
[TBL] [Abstract][Full Text] [Related]
28. Guillain-Barré syndrome during SARS-CoV-2 pandemic: A case report and review of recent literature.
Scheidl E; Canseco DD; Hadji-Naumov A; Bereznai B
J Peripher Nerv Syst; 2020 Jun; 25(2):204-207. PubMed ID: 32388880
[TBL] [Abstract][Full Text] [Related]
29. A Reminder of Skin Cancer During the COVID-19 Pandemic.
Šitum M; Filipović N; Buljan M
Acta Dermatovenerol Croat; 2021 Apr; 291(1):58. PubMed ID: 34477068
[TBL] [Abstract][Full Text] [Related]
30. The British variant of the new coronavirus-19 (Sars-Cov-2) should not create a vaccine problem.
Conti P; Caraffa A; Gallenga CE; Kritas SK; Frydas I; Younes A; Di Emidio P; Tetè G; Pregliasco F; Ronconi G
J Biol Regul Homeost Agents; 2021; 35(1):1-4. PubMed ID: 33377359
[TBL] [Abstract][Full Text] [Related]
31. Preliminary information on prevention of infections caused by SARS-COV-2 virus in endoscopic laboratories.
Gruszecka J; Filip R
Ann Agric Environ Med; 2020 Jun; 27(2):171-174. PubMed ID: 32588589
[TBL] [Abstract][Full Text] [Related]
32. Real Asymptomatic SARS-CoV-2 Infection Might Be Rare: Importance of Careful Interviews and Follow-up.
Jeong TH; Pak C; Ock M; Lee SH; Son JS; Jeon YJ
J Korean Med Sci; 2020 Sep; 35(37):e333. PubMed ID: 32959547
[TBL] [Abstract][Full Text] [Related]
33. Guillain-Barré syndrome with bilateral facial diplegia secondary to severe acute respiratory syndrome coronavirus-2 infection: a case report.
Ramirez N; Ujueta D; Diaz LF; Folleco LE; Rodríguez A; Gaona I; Nava-Mesa MO
J Med Case Rep; 2021 Nov; 15(1):558. PubMed ID: 34782002
[TBL] [Abstract][Full Text] [Related]
34. Coronavirus Disease 19 Infection Does Not Result in Acute Kidney Injury: An Analysis of 116 Hospitalized Patients from Wuhan, China.
Wang L; Li X; Chen H; Yan S; Li D; Li Y; Gong Z
Am J Nephrol; 2020; 51(5):343-348. PubMed ID: 32229732
[TBL] [Abstract][Full Text] [Related]
35. Descriptive, Retrospective Study of the Clinical Characteristics of Asymptomatic COVID-19 Patients.
Han H; Xu Z; Cheng X; Zhong Y; Yuan L; Wang F; Li Y; Liu F; Jiang Y; Zhu C; Xia Y
mSphere; 2020 Oct; 5(5):. PubMed ID: 33028689
[TBL] [Abstract][Full Text] [Related]
36. Neurological manifestations associated with SARS-CoV-2 and other coronaviruses: A narrative review for clinicians.
Maury A; Lyoubi A; Peiffer-Smadja N; de Broucker T; Meppiel E
Rev Neurol (Paris); 2021; 177(1-2):51-64. PubMed ID: 33446327
[TBL] [Abstract][Full Text] [Related]
37. SARS-CoV-2 Infection and Guillain-Barré Syndrome.
Makhluf H; Madany H
Pathogens; 2021 Jul; 10(8):. PubMed ID: 34451400
[TBL] [Abstract][Full Text] [Related]
38. [Neurological aspects of the COVID-19 pandemic caused by the SARS-CoV-2 coronavirus].
Bereczki D; Stang R; Böjti P; Kovács T
Ideggyogy Sz; 2020 May; 73(05-06):171-175. PubMed ID: 32579306
[TBL] [Abstract][Full Text] [Related]
39. The implications of preliminary screening and diagnosis: Clinical characteristics of 33 mild patients with SARS-CoV-2 infection in Hunan, China.
Yin S; Peng Y; Ren Y; Hu M; Tang L; Xiang Z; Li X; Wang M; Wang W
J Clin Virol; 2020 Jul; 128():104397. PubMed ID: 32388472
[TBL] [Abstract][Full Text] [Related]
40. Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital.
Ottaviani D; Boso F; Tranquillini E; Gapeni I; Pedrotti G; Cozzio S; Guarrera GM; Giometto B
Neurol Sci; 2020 Jun; 41(6):1351-1354. PubMed ID: 32399950
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
